About this trial
To provide detailed information on long-term outcomes in relation to potential neuroprotection and improvements in recovery for different targets of sedation, temperature, and pressure management in post out of hospital cardiac arrest survivors at 6 and 12 months. In addition, the impact of caring for a post OHCA survivor will be explored.
Eligibility criteria
Qualifiers
None
Disqualifiers
Inclusion criteria: out-of-hospital cardiac arrest of non-traumatic origin, minimum of 20 minutes without chest compressions (defined as stable return of spontaneous circulation. ROSC), unconsciousness (defined as not being able to obey verbal commands equal to a FOUR-score motor response of <4, or being intubated and sedated because of agitation after sustained ROSC, eligible for intensive care without restrictions or limitation, inclusion within 4 hours (240 minutes) of ROSC (or 220 minutes of stable ROSC).
Exclusion criteria: on ECMO prior to randomization, pregnancy, suspected or confirmed intracranial hemorrhage, previously randomized in the STEPCARE trial.
Trial design
Treatments tested in this trial
- Feed back controlled temperature device
- High MAP
- Deep sedation
- Fever control without a device
- Low MAP
- Minimal sedation
Treatment groups
8
Treatment groupsSee each treatment group below.
Sponsors and collaborators
Region Skane
Lead sponsor
Lund University
Collaborator
The George Institute for Global Health, Australia
Collaborator
Copenhagen Trial Unit, Center for Clinical Intervention Research
Collaborator
Helsinki University Central Hospital
Collaborator